N44CO120044-000 (N44) | |||
---|---|---|---|
Title | "Generic Erbitux for Treatment of EGFR+ Cancer." | ||
Institution | CANCER THERAPEUTICS LABORATORY INC, LOS ANGELES, CA | ||
Principal Investigator | HU, PEISHENG | NCI Program Director | N/A |
Cancer Activity | N/A | Division | N/A |
Funded Amount | $2,479,561 | Project Dates | 09/28/2012 - 09/27/2014 |
Fiscal Year | 2012 | Project Type | Contract |
Research Topics w/ Percent Relevance | Cancer Types w/ Percent Relevance | ||
Cancer (100.0%) Digestive Diseases (100.0%) |
Colon/Rectum (50.0%) | ||
Research Type | |||
Systemic Therapies - Discovery and Development | |||
Abstract | |||
No abstract available. |